4808
Autologous Correction of Primary Immunodeficiency Diseases
Monday, March 7, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Workshop
Moderator:
Troy R. Torgerson , MD PhD
Learning Objectives:
- Discuss current progress in gene therapy trials for primary immunodeficiency diseases
- Discuss potential uses of induced pluripotent stem cells for both diagnosis and treatment of primary immunodeficiency diseases
- Describe the Cas9/CRISPR system and potential methods for site-specific correction of genetic defects in autologous cells
See more of: Session